Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Finished Goods (2020 - 2022)

Historic Finished Goods for AVITA Medical (RCEL) over the last 3 years, with Q4 2022 value amounting to $610000.0.

  • AVITA Medical's Finished Goods fell 1689.37% to $610000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $610000.0, marking a year-over-year decrease of 1689.37%. This contributed to the annual value of $610000.0 for FY2022, which is N/A changed from last year.
  • Per AVITA Medical's latest filing, its Finished Goods stood at $610000.0 for Q4 2022, which was down 1689.37% from $734000.0 recorded in Q4 2021.
  • In the past 5 years, AVITA Medical's Finished Goods registered a high of $734000.0 during Q4 2021, and its lowest value of $178000.0 during Q2 2020.
  • Its 3-year average for Finished Goods is $486500.0, with a median of $517000.0 in 2021.
  • Its Finished Goods has fluctuated over the past 5 years, first surged by 13820.22% in 2021, then crashed by 1689.37% in 2022.
  • Quarter analysis of 3 years shows AVITA Medical's Finished Goods stood at $178000.0 in 2020, then skyrocketed by 312.36% to $734000.0 in 2021, then dropped by 16.89% to $610000.0 in 2022.
  • Its Finished Goods stands at $610000.0 for Q4 2022, versus $734000.0 for Q4 2021 and $424000.0 for Q2 2021.